Shanghai Pharmaceuticals Holding Co., Ltd
http://english.sphchina.com/index/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Shanghai Pharmaceuticals Holding Co., Ltd
Finance Watch: Two New VC Funds Raise $755m To Fund Innovation
Private Company Edition: Also, Medicxi’s new €200m fund will be reinvested in a portfolio of six life science companies and Silverback more than doubled its 2020 money with an $85m series C round.
Asia Deal Watch: Perceptive Launches LianBio With “China-Centric” Strategy
Headquartered in both China and US, the new firm will help partners bring drugs to China and other Asian markets. Novavax licenses COVID-19 vaccine in Japan to Takeda, following previous week’s deal for the vaccine in India.
Tough Going Forces Chinese Biotechs To Form Domestic Alliances
Deals among domestic Chinese biotechs are growing fast, reflecting a need to huddle up amid tightening scrutiny over biotech deal-making and an unusually competitive immuno-oncology market.
Access Pains After Approval In China? Consider The 'Three Ps'
Still a largely self-pay market, China is in the middle of a new drug approvals rush with 48 clearances in 2018 and more pending, forcing manufacturers to innovate their access models. Among several emerging strategies, a "Three P" combination of pricing, private insurance and patient assistance seems to be winning the day.
Company Information
- Industry
- Distributors
- Medical Devices
- Pharmaceuticals
- Services
-
Pharmaceuticals
- OTC, Consumer
- Other Names / Subsidiaries
-
- Beijing Kyuan Pharmaceutical Co., Ltd.
- Cardinal Health China
- Techpool Bio-pharma Co., Ltd
- Shanghai Pharmaceutical Group Co., Ltd.